InvestorsHub Logo
Followers 1075
Posts 26337
Boards Moderated 12
Alias Born 01/11/2016

Re: None

Saturday, 02/15/2020 1:21:23 PM

Saturday, February 15, 2020 1:21:23 PM

Post# of 503
NeuroBo Pharmaceuticals, Inc. (the “Company” or “NeuroBo”) is a clinical-stage biopharmaceutical company with three drug programs to impact a range of indications in neurodegenerative and cardiometabolic disease.
NeuroBo is currently focused on development of treatments for Painful Diabetic Neuropathy (PDN) with NB-01, Alzheimer’s Disease and other dementias with NB-02, and Dyslipidemias including orphan and prevalent indications with Gemcabene.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRBO News